Brighton Jones’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Other funds holding CORT
Brighton Jones's CORT Position: Q3 2026 in Review
Brighton Jones increased its Corcept Therapeutics (CORT) stake by 52% in Q3 2026, buying an estimated $416K and bringing the position to 11,335 shares worth $1.31M. The position accounts for 0.02% of the portfolio, ranked #426.
Brighton Jones first reported a position in CORT in Q3 2025 and has held it in 3 quarters since. 403 funds tracked by Wall St. Rank hold CORT as of Q3 2026.
- Brighton Jones held 11,335 shares of Corcept Therapeutics worth $1.31M as of Q3 2026.
- Brighton Jones bought 3,872 Corcept Therapeutics shares in Q3 2026, an estimated $416K.
- Corcept Therapeutics made up 0.02% of Brighton Jones's portfolio in Q3 2026, its #426 holding.
- Brighton Jones first reported a position in Corcept Therapeutics in Q3 2025 and has held it in 3 quarters since.
- 403 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.